Dr Cesar Rodriguez is an Associate Professor of Medicine at The Icahn School of Medicine and Clinical Director for Multiple Myeloma at Mount Sinai Hospital, Tisch Cancer Institute. Dr. Rodriguez received his medical degree in Monterrey, Mexico and completed training in Internal Medicine at Texas Tech University and a fellowship in Hematology/Oncology at the University of Louisville. He received transplant training at Seattle Cancer Care Alliance, Memorial Sloan Kettering, and Massachusetts General Hospital. He is part of the Wake Forest Institute of Regenerative Medicine, ASBMT Practice Guidelines Committee, BMT-CTN Myeloma Committee, Alliance Myeloma Committee, and the International Myeloma Working Group
Dr Rodriguez is a clinical and translational researcher with focus on early phase clinical trials on immunotherapy for myeloma and other plasma cell disorders. His laboratory focuses on 3-dimensional culture models and bioprinting to study the biology of myeloma cells and bone marrow microenvironment interactions that lead to drug resistance and tumor proliferation.
Scientific Archives is a global publisher initiated with the mission of ensuring equal opportunity for accessing science to research community all over the world. Spreading research findings with great relevance to all channels without any barrier is our goal. We want to overcome the challenges of Open Access with ensured quality and transparency.